TrialJournal of neuro-oncology2015

Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.

Douglas E Ney et al.PubMed ↗Publisher ↗

No numbers read from the abstract.